These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22330683)

  • 1. Targeting glucose metabolism for cancer therapy.
    Hamanaka RB; Chandel NS
    J Exp Med; 2012 Feb; 209(2):211-5. PubMed ID: 22330683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.
    Talekar M; Boreddy SR; Singh A; Amiji M
    Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC and metabolism on the path to cancer.
    Hsieh AL; Walton ZE; Altman BJ; Stine ZE; Dang CV
    Semin Cell Dev Biol; 2015 Jul; 43():11-21. PubMed ID: 26277543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments.
    Tang Q; Wu S; Zhao B; Li Z; Zhou Q; Yu Y; Yang X; Wang R; Wang X; Wu W; Wang S
    Biomed Pharmacother; 2024 Sep; 178():117257. PubMed ID: 39137648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cancer energy metabolism: a potential systemic cure for cancer.
    Kim SY
    Arch Pharm Res; 2019 Feb; 42(2):140-149. PubMed ID: 30656605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.
    Gaglio D; Metallo CM; Gameiro PA; Hiller K; Danna LS; Balestrieri C; Alberghina L; Stephanopoulos G; Chiaradonna F
    Mol Syst Biol; 2011 Aug; 7():523. PubMed ID: 21847114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting glycolysis for cancer therapy using drug delivery systems.
    Huang Y
    J Control Release; 2023 Jan; 353():650-662. PubMed ID: 36493949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastatic breast cancer cells display downregulation of PKC-ζ with enhanced glutamine metabolism.
    Tandon M; Othman AH; Winogradzki M; Pratap J
    Gene; 2021 Apr; 775():145419. PubMed ID: 33444686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking metabolic reprogramming to therapy resistance in cancer.
    Morandi A; Indraccolo S
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):1-6. PubMed ID: 28065746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose metabolism and cancer.
    Shaw RJ
    Curr Opin Cell Biol; 2006 Dec; 18(6):598-608. PubMed ID: 17046224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting metabolic reprogramming in KRAS-driven cancers.
    Kawada K; Toda K; Sakai Y
    Int J Clin Oncol; 2017 Aug; 22(4):651-659. PubMed ID: 28647837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism.
    Zeng Q; Chen J; Li Y; Werle KD; Zhao RX; Quan CS; Wang YS; Zhai YX; Wang JW; Youssef M; Cui R; Liang J; Genovese N; Chow LT; Li YL; Xu ZX
    Oncogene; 2017 Mar; 36(9):1245-1255. PubMed ID: 27546620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.
    Daye D; Wellen KE
    Semin Cell Dev Biol; 2012 Jun; 23(4):362-9. PubMed ID: 22349059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic changes during carcinogenesis: potential impact on invasiveness.
    Smallbone K; Gatenby RA; Gillies RJ; Maini PK; Gavaghan DJ
    J Theor Biol; 2007 Feb; 244(4):703-13. PubMed ID: 17055536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKM2 contributes to cancer metabolism.
    Wong N; Ojo D; Yan J; Tang D
    Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach.
    Zafari N; Velayati M; Damavandi S; Pourali G; Mobarhan MG; Nassiri M; Hassanian SM; Khazaei M; Ferns GA; Avan A
    Curr Pharm Des; 2022; 28(36):2995-3009. PubMed ID: 36154599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digging deeper through glucose metabolism and its regulators in cancer and metastasis.
    Ghanavat M; Shahrouzian M; Deris Zayeri Z; Banihashemi S; Kazemi SM; Saki N
    Life Sci; 2021 Jan; 264():118603. PubMed ID: 33091446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
    Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic targets of tumor metabolism.
    Kishton RJ; Rathmell JC
    Cancer J; 2015; 21(2):62-9. PubMed ID: 25815845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.